Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023954822> ?p ?o ?g. }
- W2023954822 endingPage "245" @default.
- W2023954822 startingPage "233" @default.
- W2023954822 abstract "The Nlrp3 inflammasome is activated in response to an array of environmental and endogenous molecules leading to caspase-1-dependent IL-1β processing and secretion by myeloid cells. Several identified Nlrp3 inflammasome activators also trigger reactive oxygen species (ROS) production. However, the initial concept that NADPH oxidases are the primary source of ROS production during inflammasome activation is becoming less accepted. Therefore, the importance of mitochondria-derived ROS has been recently explored. In this study, we explore the impact of mitochondria dysfunction and ROS production on Nlrp3 inflammasome stimulation and IL-1β secretion induced by serum amyloid A (SAA) in primary mouse peritoneal macrophages. To induce mitochondrial dysfunction, we utilized antimycin A, which blocks electron flow at complex III, and carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP), a mitochondrial oxidative phosphorylation uncoupler. We also utilized a superoxide dismutase mimetic, MnTBAP, which targets the mitochondria, as well as the broad-spectrum antioxidants DPI (diphenyleneiodonium chloride) and ebselen. Our findings demonstrate that SAA alone induces mitochondrial ROS in a time-dependent manner. We observed that MnTBAP and ebselen blocked IL-1β secretion caused by SAA only when added before stimulation, and DPI augmented IL-1β secretion. Surprisingly, these effects were not directly related to intracellular or mitochondrial ROS levels. We also found that mitochondria-targeted drugs increased IL-1β secretion regardless of their impact on mitochondrial function and ROS levels, suggesting that mitochondrial ROS-dependent and -independent mechanisms play a role in the Nlrp3 inflammasome/IL-1β secretion axis in SAA-stimulated cells. Finally, we found that FCCP significantly sustained the association of the Nlrp3 inflammasome complex, which could explain the most robust effect among the drugs tested in enhancing IL-1β secretion in SAA-treated cells. Overall, our data suggest that the Nlrp3 inflammasome/IL-1β secretion axis is a very highly regulated inflammatory pathway that is susceptible not only to changes in mitochondrial or intracellular ROS, but also to changes in overall mitochondrial function." @default.
- W2023954822 created "2016-06-24" @default.
- W2023954822 creator A5029948229 @default.
- W2023954822 creator A5063373290 @default.
- W2023954822 creator A5063624003 @default.
- W2023954822 creator A5065900243 @default.
- W2023954822 creator A5068254190 @default.
- W2023954822 date "2013-07-01" @default.
- W2023954822 modified "2023-10-02" @default.
- W2023954822 title "Mitochondria-targeted drugs enhance Nlrp3 inflammasome-dependent IL-1β secretion in association with alterations in cellular redox and energy status" @default.
- W2023954822 cites W1605844554 @default.
- W2023954822 cites W1817088045 @default.
- W2023954822 cites W1824975628 @default.
- W2023954822 cites W1968564077 @default.
- W2023954822 cites W1972701711 @default.
- W2023954822 cites W1985538633 @default.
- W2023954822 cites W1992359197 @default.
- W2023954822 cites W1996754414 @default.
- W2023954822 cites W2002033816 @default.
- W2023954822 cites W2004956526 @default.
- W2023954822 cites W2009004909 @default.
- W2023954822 cites W2013103361 @default.
- W2023954822 cites W2013682061 @default.
- W2023954822 cites W2018607502 @default.
- W2023954822 cites W2026525843 @default.
- W2023954822 cites W2028017703 @default.
- W2023954822 cites W2034946303 @default.
- W2023954822 cites W2042767581 @default.
- W2023954822 cites W2048032544 @default.
- W2023954822 cites W2054571187 @default.
- W2023954822 cites W2064399682 @default.
- W2023954822 cites W2064575677 @default.
- W2023954822 cites W2068048197 @default.
- W2023954822 cites W2073665583 @default.
- W2023954822 cites W2084255431 @default.
- W2023954822 cites W2085580435 @default.
- W2023954822 cites W2092266379 @default.
- W2023954822 cites W2092984629 @default.
- W2023954822 cites W2096317294 @default.
- W2023954822 cites W2100700890 @default.
- W2023954822 cites W2105892074 @default.
- W2023954822 cites W2107640432 @default.
- W2023954822 cites W2114769428 @default.
- W2023954822 cites W2115893060 @default.
- W2023954822 cites W2118731822 @default.
- W2023954822 cites W2119828139 @default.
- W2023954822 cites W2127854030 @default.
- W2023954822 cites W2134931914 @default.
- W2023954822 cites W2140101990 @default.
- W2023954822 cites W2157601642 @default.
- W2023954822 cites W2160038863 @default.
- W2023954822 cites W2164959400 @default.
- W2023954822 cites W2165275387 @default.
- W2023954822 cites W2314044888 @default.
- W2023954822 doi "https://doi.org/10.1016/j.freeradbiomed.2013.01.025" @default.
- W2023954822 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3705582" @default.
- W2023954822 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23376234" @default.
- W2023954822 hasPublicationYear "2013" @default.
- W2023954822 type Work @default.
- W2023954822 sameAs 2023954822 @default.
- W2023954822 citedByCount "78" @default.
- W2023954822 countsByYear W20239548222013 @default.
- W2023954822 countsByYear W20239548222014 @default.
- W2023954822 countsByYear W20239548222015 @default.
- W2023954822 countsByYear W20239548222016 @default.
- W2023954822 countsByYear W20239548222017 @default.
- W2023954822 countsByYear W20239548222018 @default.
- W2023954822 countsByYear W20239548222019 @default.
- W2023954822 countsByYear W20239548222020 @default.
- W2023954822 countsByYear W20239548222021 @default.
- W2023954822 countsByYear W20239548222022 @default.
- W2023954822 countsByYear W20239548222023 @default.
- W2023954822 crossrefType "journal-article" @default.
- W2023954822 hasAuthorship W2023954822A5029948229 @default.
- W2023954822 hasAuthorship W2023954822A5063373290 @default.
- W2023954822 hasAuthorship W2023954822A5063624003 @default.
- W2023954822 hasAuthorship W2023954822A5065900243 @default.
- W2023954822 hasAuthorship W2023954822A5068254190 @default.
- W2023954822 hasBestOaLocation W20239548222 @default.
- W2023954822 hasConcept C170493617 @default.
- W2023954822 hasConcept C185592680 @default.
- W2023954822 hasConcept C2775838275 @default.
- W2023954822 hasConcept C2776151105 @default.
- W2023954822 hasConcept C2777209026 @default.
- W2023954822 hasConcept C2778175917 @default.
- W2023954822 hasConcept C28859421 @default.
- W2023954822 hasConcept C48349386 @default.
- W2023954822 hasConcept C49039625 @default.
- W2023954822 hasConcept C55493867 @default.
- W2023954822 hasConcept C86803240 @default.
- W2023954822 hasConcept C95444343 @default.
- W2023954822 hasConceptScore W2023954822C170493617 @default.
- W2023954822 hasConceptScore W2023954822C185592680 @default.
- W2023954822 hasConceptScore W2023954822C2775838275 @default.
- W2023954822 hasConceptScore W2023954822C2776151105 @default.
- W2023954822 hasConceptScore W2023954822C2777209026 @default.
- W2023954822 hasConceptScore W2023954822C2778175917 @default.
- W2023954822 hasConceptScore W2023954822C28859421 @default.